Brief: Relief Therapeutics, Acer Therapeutics Report EC Orphan Drug Tag For ACER-001

MindMaze Therapeutics Holding SA

12/08/2022 13:46

Aug 12 (Reuters) - Acer Therapeutics Inc  ACER.O :
    * RELIEF THERAPEUTICS AND ACER THERAPEUTICS ANNOUNCE THAT
EUROPEAN
COMMISSION HAS GRANTED ORPHAN DRUG DESIGNATION FOR ACER-001 IN
MAPLE SYRUP URINE DISEASE

Source text for Eikon:  ID:nGNX9BKS5F 
Further company coverage:  ACER.O 

 ((Reuters.Briefs@thomsonreuters.com;))